Navigation Links
AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
Date:8/7/2012

REDWOOD CITY, Calif., Aug. 7, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it will release second quarter 2012 financial results after market close on Thursday, August 9, 2012. AcelRx management will host an investment-community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) on August 9, 2012 to discuss the financial results and provide a corporate update.

Investors who wish to participate in the conference call may do so by dialing (800) 860-2442 for domestic callers, or (412) 858-4600 for international callers. Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of the company's website at www.acelrx.com.

A webcast replay will be available on the AcelRx website for 90 days following the call by visiting the Investor Relations section of the company's website at www.acelrx.com.

About AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, the ARX-01 Sufentanil NanoTab PCA System, which is currently in Phase 3 clinical development, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the inherent potential for programming and delivery errors associated with the complexity of infusion pumps. AcelRx
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
2. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
3. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
4. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
5. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
6. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 02, 2015 Research and Markets ( ... Incision Closures - Global Strategic Business Report" report to ... for the US, Canada , ... Asia-Pacific , Latin America , and ... markets for Surgical Incision Closures in US$ Million by the ...
(Date:6/2/2015)... 2, 2015  Only a quarter of physicians who ... patients they prescribe them to, according to new survey ... Medicine (BUSM) and myCME , Haymarket Medical ... Alford, M.D. , director of BUSM,s Safe and ... said, "This indicates a critical need for provider education ...
(Date:6/2/2015)... June 2, 2015  ErgoNurse, the leader in bedside safety ... products in the United States , have ... long-term care and skilled nursing markets. ... Thousands of ... fully take advantage of the ErgoNurse products to stop unnecessarily ...
Breaking Medicine Technology:Surgical Incision Closures - Global Strategic Business Report 2015 2Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2
... July 22, and OSAKA, Japan, July 23 ... Takeda Global Research & Development Center, Inc., a wholly ... U.S. Food and Drug Administration (FDA) that the FDA ... for the fixed-dose combination (FDC) of alogliptin and ACTOS((R)) ...
... , MENLO PARK, Calif., July 22 Apieron, ... positive coverage policy for the measurement of exhaled nitric oxide ... peer-reviewed evidence is sufficient to support benefit coverage for the ... the measurement of exhaled nitric oxide is considered medically necessary ...
Cached Medicine Technology:Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) 2Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) 3CareFirst BCBS Covers eNO Measurement for Diagnosis, Asthma Treatment 2
(Date:6/2/2015)... NC (PRWEB) June 02, 2015 Food ... hosting its sixth annual “Thriller on the Griller” events, ... Carolina and South Carolina locations. Each event will raise ... dedicated to restoring a sense of self, restoring the ... and our military families. , Through these events, ...
(Date:6/2/2015)... June 02, 2015 Highly qualified dental care ... plan to drive prolific change in the dental tourism industry ... Team Dental Clinic offers a full range of superior ... structure for dental tourism. , Partnered with a top ... committed to advancing dentistry and has earned a reputation as ...
(Date:6/2/2015)... The term “Augmented Reality” was coined in ... the real world. Since then many promising technologies have ... map of the vasculature on the surface of the ... AccuVein, the leader in vein visualization, exemplifies this growth ... such widespread adoption of its AccuVein AV400 devices that ...
(Date:6/2/2015)... “ Radaris ” was featured on NewsWatch as ... the latest and coolest applications on the market for iOS, ... technology expert, conducted the app review and shared with viewers ... a person. , According to Psychology Today, humans are a ... explain that curiosity is a part of human development. People ...
(Date:6/2/2015)... FL (PRWEB) June 02, 2015 MedPro ... staffing services to healthcare facilities, today announced the worldwide ... and effective mobile tool to help candidates find best ... Glassdoor survey released in 2014, 9 in 10 job ... during their job search. , The MedPro Top Jobs ...
Breaking Medicine News(10 mins):Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 3Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2
... French study in rats finds olanzapine changes metabolism in ... of the antipsychotic medication olanzapine may put a person ... 2 diabetes, new findings show. , A team of ... found that, after consuming olanzapine over several weeks, the ...
... the Country Gather to Discuss, Interactive Patient Care Topics and ... ... Patient Experience, WASHINGTON, April 7, 2008 ... today,announced the kick-off of GetConnected2008. Designed exclusively for the,GetWellNetwork community, ...
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), ... live webcast at 8:30 am (EDT) on Thursday, April ... discuss the Company,s April 7, 2008,meeting with The US ... for the Company,s novel once-a-day oral antibiotic, cethromycin,as a ...
... is caused by mutations that allow defective blood ... effective therapies it is crucial to know which mutations ... leukaemic cells. Researchers from the European Molecular Biology Laboratory ... the Universities of Harvard, USA, and Lund, Sweden, have ...
... N.Y., April 7, 2008 CardWorks Servicing, LLC,("CardWorks") ... known as Cardholder Management Services, LLC ("CMS"), announced,today ... the new HumanaAdvance,Visa Card. CardWorks will partner with ... offer the HumanaAdvance Visa. Humana,is one of the ...
... treatment aren,t known, researchers say , , MONDAY, April 7 ... bone density and reduce bone loss in older men ... prevent osteoporosis, a new study suggests. , Testosterone ... muscle mass in some men. However, the hormone treatment ...
Cached Medicine News:Health News:Antipsychotic Drug Boosts Risk of Heart Disease, Diabetes 2Health News:GetWellNetwork Kicks Off GetConnected2008, First Annual Users Conference 2Health News:GetWellNetwork Kicks Off GetConnected2008, First Annual Users Conference 3Health News:Advanced Life Sciences to Host Conference Call to Discuss April 7th Meeting with FDA 2Health News:Advanced Life Sciences to Host Conference Call to Discuss April 7th Meeting with FDA 3Health News:An unexpected way to cause leukemia 2Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 2Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 3Health News:Testosterone Therapy May Reduce Bone Loss in Older Men 2
Angled for temporal approach. Solid 14 mm blades. Dull finish....
Open 11 mm blades. Polished finish....
Open 10 mm blades. Dull finish....
Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....
Medicine Products: